"Cronos is a small company. During the past year of results to Sept. 30, it posted product sales of just $2.6-million. Most of the income it has recorded has been from the sale of shares in other marijuana stocks, including ABcann Global Corp. and The Hydropothecary Corp. Yet, the company has a market cap of $1.5-billion."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.